☆GILEAD SCIENCES, INC. (GILD)
Quality Q
0.630
AUM ($M)
1,649
Positions
5
Turnover
0.36
Top-10 wt
100%
Herfindahl
0.445
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 6 positions · portfolio value $1,649M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆RCUS funds › | Arcus Biosciences Inc. | HOLD | — | 58.8% | +26.7% | 968.8 | 31,424,760 | +0 | 0 | — |
| ☆LKFT funds › | Lakefront Biotherapeutics | HOLD | — | 30.3% | +6.7% | 500.2 | 16,707,477 | +0 | 0 | — |
| ☆ASMB funds › | Assembly Biosciences Inc. | ADD | — | 8.3% | +2.4% | 136.8 | 4,977,089 | +471,698 | 0 | — |
| ☆KYTX funds › | Kyverna Therapeutics Inc. | HOLD | — | 2.2% | +0.5% | 36.8 | 4,126,119 | +0 | 0 | — |
| ☆CUSIP:98422T100 funds › | Xilio Therapeutics Inc. | HOLD | — | 0.4% | +0.1% | 6.2 | 650,389 | +0 | 0 | — |
| ☆CUSIP:03940C100 funds › | Arcellx Inc | EXIT | — | 0.0% | -36.4% | 0.0 | 0 | -6,720,803 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 1,649 | 5 | 0.36 | 100% | 0.445 | 0.629 | — | in |
| 2026Q1 | 2,118 | 6 | 0.14 | 100% | 0.295 | 0.935 | — | in |
| 2025Q4 | 1,936 | 6 | 0.17 | 100% | 0.289 | 0.895 | — | in |
| 2025Q3 | 1,791 | 9 | 0.08 | 100% | 0.262 | 0.945 | — | in |
| 2025Q2 | 1,280 | 14 | 0.04 | 100% | 0.295 | 0.958 | — | entered |
| 2025Q1 | 1,181 | 14 | 0.00 | 100% | 0.310 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status